Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New HIV integrase inhibitors prepared and tested at BMS

Jan. 27, 2005

Merck's HIV/AIDS vaccine candidate enters collaborative phase II study

Jan. 27, 2005

Enrollment completed in phase III HARS study of Serostim

Jan. 26, 2005

Contribution of IL-7 to the elimination of HIV-1 reservoirs/News in Context

Jan. 25, 2005

Agents for HIV infection disclosed in a patent

Jan. 25, 2005

NIAID begins second phase I study of HIV vaccine

Jan. 21, 2005

HIV compound SPD-754 licensed to Avexa

Jan. 20, 2005

Phase I study of ADMVA HIV vaccine opens enrollment

Jan. 18, 2005

New HIV integrase inhibitors developed by Tibotec-Virco

Jan. 17, 2005

sanofi-aventis patent claims CCR2B receptor antagonists

Jan. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...